SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.901
AS - Asia 21.417
EU - Europa 15.112
SA - Sud America 3.620
Continente sconosciuto - Info sul continente non disponibili 1.306
AF - Africa 500
OC - Oceania 74
AN - Antartide 1
Totale 76.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.712
SG - Singapore 8.170
FI - Finlandia 4.768
CN - Cina 4.503
IT - Italia 3.251
BR - Brasile 2.808
VN - Vietnam 2.324
DE - Germania 1.988
HK - Hong Kong 1.711
BD - Bangladesh 1.364
GB - Regno Unito 977
FR - Francia 773
UA - Ucraina 733
TR - Turchia 645
JP - Giappone 630
CA - Canada 600
IN - India 531
PL - Polonia 503
RU - Federazione Russa 452
SE - Svezia 432
ID - Indonesia 410
MX - Messico 370
NL - Olanda 303
AR - Argentina 273
ZA - Sudafrica 188
ES - Italia 184
IQ - Iraq 182
CO - Colombia 138
PK - Pakistan 133
EC - Ecuador 132
AT - Austria 130
BE - Belgio 99
LT - Lituania 79
UZ - Uzbekistan 78
PH - Filippine 77
SA - Arabia Saudita 77
VE - Venezuela 77
MY - Malesia 73
AU - Australia 67
KR - Corea 67
IE - Irlanda 64
CH - Svizzera 58
MA - Marocco 58
JM - Giamaica 55
CZ - Repubblica Ceca 54
CL - Cile 53
AE - Emirati Arabi Uniti 49
EG - Egitto 48
PY - Paraguay 44
TN - Tunisia 43
JO - Giordania 41
KE - Kenya 40
PE - Perù 38
NP - Nepal 37
UY - Uruguay 34
IR - Iran 33
AL - Albania 32
TH - Thailandia 31
DZ - Algeria 26
CR - Costa Rica 24
LB - Libano 24
KZ - Kazakistan 23
PT - Portogallo 23
HN - Honduras 22
TW - Taiwan 22
DO - Repubblica Dominicana 21
IL - Israele 21
AZ - Azerbaigian 20
DK - Danimarca 20
KG - Kirghizistan 20
HR - Croazia 19
NI - Nicaragua 19
OM - Oman 19
RO - Romania 19
SN - Senegal 19
ET - Etiopia 18
PS - Palestinian Territory 16
MD - Moldavia 15
PA - Panama 15
RS - Serbia 15
BG - Bulgaria 14
CY - Cipro 13
GT - Guatemala 13
HU - Ungheria 13
SI - Slovenia 13
SV - El Salvador 13
TT - Trinidad e Tobago 12
BO - Bolivia 11
GE - Georgia 11
BH - Bahrain 9
GR - Grecia 9
LV - Lettonia 9
NO - Norvegia 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
CI - Costa d'Avorio 8
XK - ???statistics.table.value.countryCode.XK??? 8
BY - Bielorussia 7
GY - Guiana 7
KW - Kuwait 7
Totale 75.468
Salva come PNG Salva come JPEG
Città #
Singapore 4.938
Ashburn 4.843
Helsinki 4.367
San Jose 2.896
Fairfield 2.307
Woodbridge 1.819
Hong Kong 1.668
Santa Clara 1.564
Beijing 1.410
Dallas 1.402
Houston 1.257
Chandler 1.035
Munich 1.029
Seattle 991
New York 930
Council Bluffs 876
Wilmington 856
Los Angeles 813
Ann Arbor 810
Jacksonville 775
Cambridge 767
Ho Chi Minh City 765
Tokyo 595
Hanoi 519
Warsaw 473
Lauterbourg 413
Milan 409
Ferrara 387
Izmir 344
Princeton 326
São Paulo 311
Jakarta 296
Shanghai 290
Nanjing 272
Chicago 226
Mexico City 216
San Diego 216
Orem 215
Toronto 215
London 214
Buffalo 212
Rome 194
Turku 187
Bologna 180
Boardman 166
Frankfurt am Main 160
Montreal 157
Phoenix 151
Atlanta 141
Brooklyn 138
Chennai 131
Denver 131
Hefei 121
Nuremberg 116
Rio de Janeiro 112
The Dalles 107
San Francisco 106
Da Nang 104
Amsterdam 102
Haiphong 102
Boston 98
Stockholm 97
Brussels 96
Johannesburg 94
Moscow 94
Tianjin 89
Manchester 84
Washington 84
Poplar 81
Bremen 80
Shenyang 78
Mumbai 74
Falkenstein 73
Nanchang 72
Tashkent 69
Baghdad 64
Lappeenranta 64
Redwood City 64
Falls Church 63
Columbus 61
Naples 61
Ankara 58
Paris 56
Guangzhou 55
Jiaxing 55
Salt Lake City 55
Belo Horizonte 54
Dhaka 54
Dublin 52
Quito 52
Charlotte 49
Biên Hòa 48
Changsha 48
Medellín 48
Newark 47
Turin 45
Mountain View 44
Shenzhen 44
Brasília 43
New Delhi 43
Totale 49.463
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 2.871
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.061
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 438
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 432
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 431
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 378
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 375
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 363
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 351
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 351
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 339
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 320
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 308
Poor response to clopidogrel: current and future options for its management 307
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 300
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 298
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 286
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 286
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 276
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 276
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 267
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 265
Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study 264
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 264
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 263
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 258
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 258
Characterization of Dermal Stem Cells of Diabetic Patients 255
Reperfusion Damage - A Story of Success, Failure, and Hope 254
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 254
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 253
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 253
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 252
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 248
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 248
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 247
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 244
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 244
The Mitochondrial Permeability Transition Pore 243
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 242
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 239
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 239
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 238
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 238
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 233
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 232
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 232
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 231
Mechanistic role of mPTP in ischemia-reperfusion injury 231
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial 230
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 227
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 225
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 224
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 224
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 222
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 222
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 221
Can we improve myocardial protection during ischaemic injury? 221
A serum proteome signature to predict mortality in severe COVID-19 patients 221
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 220
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 219
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 218
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 218
Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review 216
BRS implantation in long lesions requiring device overlapping: Myth or reality? 216
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 215
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 214
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 211
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 210
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 209
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 209
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 208
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 207
The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review 206
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 206
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 206
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 205
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 205
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 204
Structural Abnormalities in Brugada Syndrome and Non-Invasive Cardiac Imaging: A Systematic Review 203
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 203
Notch Signaling Regulates Immune Responses in Atherosclerosis 203
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 203
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 202
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 202
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 201
Fractional flow reserve: Current applications and overview of the available data 200
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 200
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 200
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 200
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 198
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 198
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 197
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 197
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 197
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 197
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 196
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 195
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 195
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 195
Totale 28.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 352.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.219
Totale 355.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.887 0 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/202512.666 313 330 920 586 1.425 1.211 806 708 2.320 1.302 1.514 1.231
2025/202639.345 2.969 1.574 3.299 3.858 4.751 2.088 3.630 1.945 7.207 3.898 2.448 1.678
2026/20272.844 1.454 1.390 0 0 0 0 0 0 0 0 0 0
Totale 76.931